Skip to content

Evaluation of Dynamic Balance After Recovery From COVID 19 Disease

Evaluation of Dynamic Balance After Recovery From COVID 19 Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05813886
Enrollment
25
Registered
2023-04-14
Start date
2022-02-20
Completion date
2023-03-21
Last updated
2023-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19 Respiratory Infection

Brief summary

effect of post covid-19 on dynamic balance in patients after recovery from covid-19 disease.

Detailed description

effect of post covid-19 on dynamic balance in patients after recovery from COVID disease. patients will treated with medical protocol of COVID 19 an out-patient clinic , and followed up by the chest specialist . The balance tests of the patients were performed 2 to 14 weeks after their recovery from the disease, which was confirmed by the evaluations of the COVID staff and negative polymerase chain reaction test.the patients will evaluated using questionnaires. First, the question will whether feeling in balance in the daily life or not. The answer will classified as yesor no. Second, asked to fill Dizziness Handicap Inventory(DHI), which is a multidimensional self- assessment scale created to evaluate the effects of dizziness and balance problems on the quality of life as well as the level of disability of the patients. Assess balance , which consists of a movable balance platform that provides up to 20 of surface tilt in a 360 range of motion. The platform is interfaced with computer software that enables the device to serve as an objective assessment of balance . The measure of postural stability includes the overall (OA), the anteroposterior (AP) and the mediolateral (ML) stability scores. A high score in the OA index indicates poor balance. The OA stability score is believed to be the best indicator of the overall ability of the patient to balance the platform

Interventions

The balance tests of the patients were performed 2 to24 WEEKS after their recovery from the disease, which was confirmed by the evaluations of the Covid-19 staff and negative polymerase chain reaction test.

Sponsors

October 6 University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
30 Years to 40 Years

Inclusion criteria

* 25post COVID-19 patients suffering from inbalance. * Age will be ranged from 30 to 40 years old. * Body mass index (BMI) will be ranged from 25 to 35 Kg/m2. * Diagnosed as COVID-19 patients with a positive reverse transcription polymerase chain reaction (RT-PCR) result of SARS-CoV-2, or typical computerized tomography (CT) evidence of viral pneumonia. * All enrolled patients with moderate covid-19 infection.

Exclusion criteria

* Severe disease or hospitalization at intensive care units will excluded from the study. * Patients with previous hearing problems or balance disorders. * Patients who had ear surgery, cardiovascular and circulatory problems,. * Patients with orthopedic problems in the lower extremities due to other problems * Patients with Any history of neurological or psychiatric disease, severe visual or auditory impairments. * Diabetic patients.

Design outcomes

Primary

MeasureTime frameDescription
overall (OA), the anteroposterior (AP) and the Medio lateral (ML) stability scores2 to24 WEEKS after their recovery from the diseaseA high score in the OA index indicates poor balance. The OA stability score is believed to be the best indicator of the overall ability of the patient to balance the platform

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026